Time
Days to earnings15
Next print2026-11-02
WindowAMC
Fiscal2026-09-30
NASDAQ · HEALTHCARE · BIOTECHNOLOGY
VRTX
Vertex Pharmaceuticals Inc primary
507.00
Full stocks workspace →-3.08-0.6%
Street
Consensus EPS-1.20
Consensus revenue3.4B
EPS high / low5.06 / -29.51 · 2881.1% · n=12
Rev / avg0 / — · -1.22 / -2.348
Options
IV front24.9%
Implied move6.0%
Put/call full0.94
Put/call front0.96
Short interest
Short shares4.5M / 4.7M · -4.53%
Days to cover4.24
Avg vol · float1.1M · 253.2M
Short % float1.78%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 15 | 2026-11-02 | 507.00 | -1.20 | 24.9% | 6.0% | +0.7% | -3.9% | -2.4% | -6.4% | 5.06 / -29.51 | 2881.1% | 12 | 0.94 | 0 | |
| 2026-10-09 | 16 | 2026-11-02 | 510.08 | -1.22 | 26.4% | 6.8% | +1.1% | -3.1% | -1.0% | -6.8% | 5.06 / -29.56 | 2837.9% | 12 | 0.95 | 0 | |
| 2026-10-08 | 17 | 2026-11-02 | 503.25 | -1.22 | 24.4% | 6.4% | -0.7% | -3.7% | -2.2% | -8.0% | 5.06 / -29.56 | 2837.9% | 12 | 0.95 | 0 | |
| 2026-10-07 | 18 | 2026-11-02 | 505.64 | -1.22 | 24.9% | 6.6% | -3.3% | -2.1% | -3.0% | -8.5% | 5.06 / -29.56 | 2837.9% | 12 | 0.95 | 0 | |
| 2026-10-06 | 19 | 2026-11-02 | 502.31 | -1.22 | 27.3% | 7.4% | -4.6% | -2.5% | -5.0% | -8.3% | 5.06 / -29.56 | 2837.9% | 12 | 0.95 | 0 | |
| 2026-10-05 | 20 | 2026-11-02 | 503.50 | -1.22 | 25.9% | 7.2% | -4.6% | -1.4% | -7.8% | -8.1% | 5.06 / -29.56 | 2837.9% | 12 | 0.95 | 0 | |
| 2026-10-02 | 21 | 2026-11-02 | 504.73 | -1.737 | 24.9% | 7.3% | -4.1% | -0.7% | -9.5% | -6.6% | 5.06 / -29.56 | 1993.0% | 11 | 0.93 | 0 | |
| 2026-10-01 | 22 | 2026-11-02 | 506.74 | -1.737 | 28.3% | 8.4% | -3.0% | -1.9% | -9.0% | -8.2% | 5.06 / -29.56 | 1993.0% | 11 | 0.89 | 0 | |
| 2026-09-30 | 23 | 2026-11-02 | 522.81 | -1.737 | 27.8% | 8.4% | +1.3% | +1.9% | -4.5% | -1.0% | 5.06 / -29.56 | 1993.0% | 11 | 0.86 | 0 | |
| 2026-09-29 | 24 | 2026-11-02 | 526.73 | -1.737 | 27.8% | 8.5% | +2.3% | +2.4% | -3.3% | +2.2% | 5.06 / -29.56 | 1993.0% | 11 | 0.87 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| AMGN primary | Amgen Inc | 0.51 | 2026Q2 · 2026-08-04 | +12.3% | +0.9% | 407.83 | 16 · 2026-10-12 |
| GILD primary | Gilead Sciences Inc | 0.45 | 2026Q2 · 2026-08-03 | +4.5% | 0.0% | 135.25 | 13 · 2026-10-12 |
| REGN primary | Regeneron Pharmaceuticals Inc | 0.39 | 2026Q2 · 2026-07-30 | +56.6% | +0.9% | 738.34 | 14 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-03 | AMC | 4.20 | +1.2% | Beat | +0.1% | +1.6% | 1.51× | +10.3% | Review |
| 2026Q1 | 2026-05-04 | AMC | 4.47 | +3.8% | Beat | +0.5% | -1.8% | 1.95× | +2.3% | Review |
| 2025Q4 | 2026-02-12 | AMC | 5.03 | -2.3% | Miss | +1.4% | +4.2% | 1.92× | -1.1% | Review |
| 2025Q3 | 2025-11-03 | AMC | 4.80 | +4.8% | Beat | -1.7% | +0.7% | 1.69× | +3.3% | Review |
| 2025Q2 | 2025-08-04 | AMC | 4.52 | +6.4% | Beat | -13.6% | -8.1% | 7.71× | +4.2% | Review |
| 2025Q1 | 2025-05-05 | AMC | 4.06 | -5.4% | Miss | -6.9% | -3.3% | 5.60× | -0.6% | Review |
| 2024Q4 | 2025-02-10 | AMC | 3.98 | -1.0% | Miss | -2.2% | -1.0% | 0.93× | +5.2% | Review |
| 2024Q3 | 2024-11-04 | AMC | 4.38 | +6.1% | Beat | +2.2% | +3.5% | 1.72× | -10.4% | Review |
| 2024Q2 | 2024-08-01 | AMC | -12.83 | -9.2% | Miss | -2.8% | +0.6% | 1.39× | -3.5% | Review |
| 2024Q1 | 2024-05-06 | AMC | 4.76 | +17.2% | Beat | +1.0% | +0.9% | 1.54× | +7.7% | Review |